A detailed history of Ethos Financial Group, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Ethos Financial Group, LLC holds 23,700 shares of NWBO stock, worth $6,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,700
Previous 23,700 -0.0%
Holding current value
$6,162
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$0.48 - $0.69 $11,376 - $16,352
23,700 New
23,700 $12,000
Q1 2023

Apr 20, 2023

BUY
$0.58 - $0.76 $12,876 - $16,872
22,200 New
22,200 $13,000

Others Institutions Holding NWBO

About NORTHWEST BIOTHERAPEUTICS INC


  • Ticker NWBO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,037,230,016
  • Market Cap $270M
  • Description
  • Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...
More about NWBO
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.